Ikena Oncology Inc. Recorded Big Gain
Thu, Apr 07, 2022 at 05:30 PM
Ikena Oncology Inc. (IKNA:NASDAQ) jumped higher at $7.01, a gain of 25.9%. On Wed, Apr 06, 2022, IKNA:NASDAQ hit a New 2-Week Low of $5.57. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 08:03 AM in the 'INVESTOR UPDATE' category. From Thu, Mar 24, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
About Ikena Oncology Inc. (IKNA:NASDAQ)
Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.
Top 10 Gainers:
- MedAvail Holdings Inc. (MDVL:NASDAQ), 64.43%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 56.84%
- Momentus Inc. (MNTS:NASDAQ), 48.81%
- System1 Inc. Class A (SST:NYSE), 34.32%
- Vericity, Inc. (VERY:NASDAQ), 30.81%
- Ikena Oncology Inc. (IKNA:NASDAQ), 25.85%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 23.47%
- Alset EHome International Inc. (AEI:NASDAQ), 23.27%
- NeoGenomics, Inc. (NEO:NASDAQ), 21.58%